Enzyme Prijs
MLNRang 1102
Enzyme (MLN) Prijs Live Grafiek
De prijs van Enzyme (MLN) is vandaag $3.02, met een 24-uurs handelsvolume van $2.38K. Hierdoor heeft Enzyme (MLN) een marktkapitalisatie van $9.92M, wat neerkomt op een marktdominantie van 0.00036%. De prijs van Enzyme (MLN) is de afgelopen 24 uur met -1.43% veranderd.
MLN Prijsgegevens
- 24u Omzet$2.38K
- All Time High (ATH)$258.26
- 24u hoog$3.1
- All-Time Low (ATL)$1.79
- 24u Laag$3.01
MLN Marktkapitalisatie-info
- Marktkapitalisatie$9.92M
- Volledig verwaterde waardering$9.92M
- Marktkapitalisatie/FDV100%
- MarktsentimentPositief
MLN Aanbod
- Circulerend aanbod3.27M MLN
- Totale voorraad3.27M MLN
- Maximale voorraad∞
*Gegevens zijn alleen ter referentie
Enzyme(MLN) wordt voorspeld gemiddeld $3.02 te zijn in 2026, met een mogelijke schommeling tussen de laagste prijs $2.14 en de hoogste prijs $3.45. Tegen 2031 kan de prijs van Enzyme(MLN) oplopen tot $7.41, wat een potentieel rendement van +92.00% biedt ten opzichte van de huidige Enzyme-prijs.
Jaar | Minimale prijs | Hoogste prijs | Gemiddelde prijs | Verandering |
|---|---|---|---|---|
2026 | $2.14 | $3.45 | $3.02 | -- |
2027 | $3.14 | $4.34 | $3.23 | +7.00% |
2028 | $2.99 | $4.85 | $3.79 | +25.00% |
2029 | $2.54 | $5.09 | $4.32 | +42.00% |
2030 | $2.54 | $6.97 | $4.71 | +55.00% |
2031 | $4.61 | $7.41 | $5.84 | +92.00% |
De prijs van Enzyme(MLN) is de afgelopen 24 uur met -1.43% bewogen, en met -5.52% in de afgelopen 7 dagen. De prijs van Enzyme(MLN) is -7.73% in de afgelopen 30 dagen, en -66.96% over het afgelopen jaar.
Tijdsperiode | Bedrag wijzigen | % Verandering |
|---|---|---|
1H | -$0.01094 | -0.36% |
24H | -$0.04392 | -1.43% |
7D | -$0.1769 | -5.52% |
30D | -$0.2536 | -7.73% |
1Y | -$6.13 | -66.96% |
Enzyme (MLN) geloofwaardigheidsindicatoren
85.54
Betrouwbaarheidsscore
PercentielTOP 5%
Over Enzyme (MLN)
Contract
0xec67005...c47c91892
Verkenners
etherscan.io
Website
enzyme.finance
Community
the user pays for the use of mln tokens. Developers or external contributors can obtain mln tokens by submitting grants.
Enzyme (MLN) teamleden
Mona El Isa
Enzyme (MLN) Investeerders
Kenetic Capital
Placeholder Ventures
DeFiance Capital- GateNewsAccording to the Ethereum Foundation, the Glamsterdam upgrade has achieved key milestones, including consensus on a 200 million Gas Limit floor, stable ePBS external builder operation, and finalized EIP-8037 gas repricing parameters. The upgrade aims to safely increase Gas Limit and expand Ethereum
- GateNewsAccording to PANews, President Trump on May 3 criticized Tehran's leadership for blocking a deal to end a nine-week conflict driving a global energy crisis, saying Iran's demands are unacceptable. Some traders, however, interpreted his remarks as negotiating tactics rather than abandonment of
- GateNewsAccording to 10x Research founder Markus Thielen, Bitcoin has held above its 7-day and 30-day moving averages over the past week, gaining 1.1% with dominance exceeding 60%. The short to medium-term trend remains bullish, signaling continued strength in the
- GateNewsAccording to Wasabi Protocol's official statement on X, users can now safely interact with the protocol's smart contracts and withdraw remaining funds. The team is working to investigate the incident but has not disclosed additional details at this time, stating that further updates will be shared w
- GateNewsAccording to JPMorgan analysts led by managing director Nikolaos Panigirtzoglou, rising stablecoin velocity may limit market capitalization growth even as usage increases significantly. The analysts said stablecoin transaction velocity has increased sharply over the past year, allowing the same
- GateNewsAccording to Coinglass data, Bitcoin rose 11.87% and Ethereum gained 7.3% month-over-month in April 2026, marking a notable recovery for both assets.
Just checked MLN and it's trading around $3.04 USD right now, volume's pretty light at $357.61 for the day. Pretty different from what some analysts were calling earlier. If we're looking at potential moves from here, the key thing to watch is whether it can hold above the $3 level - that's becoming...GateUser-a5fa8bd0MLN-1.43%
Just saw ADMA Biologics announced a $200 mln capital return plan and honestly this is pretty solid for shareholders. They're doing a $125 mln accelerated share repurchase with JPMorgan, which means they're getting serious about returning cash. The deal structure is interesting - they're buying back ...MEVHunterX
So Intellia just got the FDA to lift the clinical hold on their MAGNITUDE Phase 3 trial for nexiguran ziclumeran - that's the ATTR cardiomyopathy drug they've been working on. The hold was put in place back in October after some liver enzyme concerns in one patient, but looks like they've worked thr...TokenomicsTherapist
Just saw BioMarin got FDA approval to expand PALYNZIQ for kids as young as 12 with PKU. Interesting move for the pediatric market—this enzyme therapy is basically the only option out there for managing blood phenylalanine levels, so expanding to younger patients makes sense from a treatment standpoi...MEV_Whisperer
Scientists found a peptide that may actually LENGTHEN your telomeres. 🧬 Epitalon activates telomerase, the enzyme your body silences as you age. CN What the research shows: → Telomere elongation in human cell cultures → 13–16% lifespan extension in animal models → Restored deep sleep & melatonin in...Emil74668- $MLN - Mcap 9.4M$ - 78%/ 9.4K votes Bullish SC02 M5 - pending Short order. Entry lies within HVN + not affected by any weak zone, the current resistance zone is approximately 1.16% wide. The downtrend has lasted for 19 hours 50 minutes, with the largest recorded price decline atGateUser-8a8ce091MLN-1.43%
